Humana execs sell $38M in shares

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

The selloff comes at a time when Humana’s share prices have been soaring, closing at a new all-time high of $365.88 on Dec. 16. Higher company earnings are matched with a rosy outlook for corporate tax cuts. In fact, 15 of Humana’s highest share price closings fell in November and December.

Humana CEO Bruce Broussard sold 62,700 shares for roughly $21.7 million, according to public filings.

Humana’s share prices, along with other major healthcare insurers, jumped on the news that a handful of Affordable Care Act taxes could be eliminated.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup